Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.

Slides:



Advertisements
Similar presentations
Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Advertisements

UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experience of Research Findings and Opportunities From NCPES (National.
Reinventing Cancer Support Ciarán Devane Chief Executive.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Delivering clinical research to make patients, and the NHS, better Lymphs & Haems Cancer Research Report Site Specific Group Meeting Weds 11 th March 2015.
Delivering clinical research to make patients, and the NHS, better Breast Cancer Research Report Site Specific Group Meeting Tuesday 13 th January 2015.
Delivering clinical research to make patients, and the NHS, better Haematological Cancer Research Report Site Specific Group Meeting Tuesday 14 th October.
Analysis of Patient Experience of Cancer Care Pathway within Merseyside & Cheshire Produced by Merseyside and Cheshire Cancer Network Presented: November.
NHS South East London Quality, Innovation, Productivity and Prevention (QIPP) plan November 2010 Submission.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
1000 Lives Annual Report North of England Cancer Network Annual Conference 20 th September 2013.
Macmillan GP Facilitator for Walsall Dr Joo Ee Teoh, St Peter’s Surgery.
Delivering clinical research to make patients, and the NHS, better Head & Neck Cancer Research Report Site Specific Group Meeting Tuesday 9 th June 2015.
AAACM – what’s going on with the trend in LCR…? …and can it be explained by cancer?
BETTER CANCER CARE A Discussion Elizabeth Porterfield Head, NHS National Planning Team SGHD.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
Network Patient Satisfaction Survey Gloria Payne, Patient & Carer Involvement Facilitator Ian Connolly, Performance Improvement Manager Lead Nurse Open.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Delivering clinical research to make patients, and the NHS, better Urology SSG 22nd April 2015 Research Wendy Cook, Research Delivery Manager Dr Mohini.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
The Wellington Experience Paul Smith and Dr A. O'Donnell Cancer Care Co-ordination.
South West Public Health Observatory South West Regional Public Health Group Trends in End of Life Care in the South West Mark Dancox, Andy Pring, Roy.
How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.
SWAG SSG Lung Cancer Meeting
SWAG SSG Skin Meeting Thursday 22nd September 2016 Maxine Taylor
SWAG SSG Sarcoma Meeting
Genomic Medicine Centre Overview
SWAG SSG Skin Cancer Meeting
SWAG SSG Head and Neck Cancer Meeting
SWAG SSG Colorectal Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
SWAG SSG Urology Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
SWAG SSG Skin Cancer Meeting Tuesday 22nd May Research Report
SWAG SSG Haematology and Lymphoma Meeting
SWAG SSG Colorectal Meeting
SWAG SSG Haematology and Lymphoma Meeting
SWAG SSG Sarcoma Cancer Meeting
SWAG SSG Gynaecology Cancer Meeting
SWAG SSG Colorectal Cancer Meeting
Genomic Medicine Centre Overview
SWAG SSG Brain and CNS Cancer Meeting
SWAG Cancer Alliance Update
Genomic Medicine Centre Overview
SWAG SSG Urology Meeting
SWAG SSG Lung Cancer Meeting
SWAG SSG Gynaecological Cancers Meeting
SWAG SSG Brain and CNS Cancer Meeting
SWAG SSG Skin Cancer Meeting
SWAG SSG Breast Cancer Meeting
SWAG Cancer Alliance Update
SWAG SSG Head and Neck Cancer Meeting
SWAG SSG Sarcoma Meeting
SWAG SSG Head and neck Cancer Meeting
SWAG SSG Sarcoma Cancer Meeting
SWAG SSG Lung Cancer Meeting
SWAG SSG Skin Cancer Meeting Wednesday 23rd May Research Report
SWAG SSG Haematology and Lymphoma Cancer Meeting
Genomic Medicine Centre Overview
SWAG SSG Lung Cancer Meeting
SWAG SSG Skin Cancer Meeting
SWAG SSG Brain Cancer Meeting
SWAG SSG Breast Cancer Meeting
SWAG SSG Upper GI Cancer Meeting
Lung Cancer Clinical Advisory Group
Presentation transcript:

Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experiences of Research Findings from the National Cancer Patient Experience Survey 2012–2014 dd/mm/yyyy (Your name here) NCRI (name of) Clinical Studies Group Member, Consumer Liaison Group

National Cancer Patient Experience Survey (NCPES) WHAT IS NCPES (aka. CPES)? Annual postal survey 70 detailed questions about experience of care WHO TAKES PART? All adult patients (16+) treated Sept-Nov All 153 Trusts in England (not UK-wide) Data on 70,141 patients in 2014 = 64% response rate ANALYSES By Cancer type, by Trust, by CCG* & by Network Detailed demographics: Age, Deprivation, Sexuality, Ethnicity…

Why the Consumer Liaison Group is involved: Can look at national trends and drill down into local practice Analyses by Cancer type, by Trust and by patient demographics: age, deprivation, sexuality, ethnicity... Results are used to bring about change Data are available to anyone: The questions about research awareness are OUR questions; introduced into NCPES 2012, following representations from the CLG, including the topics to be covered by the questions (amended in 2013)

Responses Show: It’s OK To Ask! 1/3 of cancer patients are having discussions about research 2/3 of those asked go on to take part in research 95% of those asked are glad to be asked  53% of those not asked would be glad to be asked Taking part in research is associated with better experience of care  Significant and persistent variations:- by cancer, by age, by network and by Trust

NCPES: 2012 Research Awareness Questions In 2012 we added our first 3 questions: Since your diagnosis, has anyone discussed with you whether you would like to take part in cancer research?Yes 33% If yes, were you glad to have been asked?Yes 95% If no, would you like to have been asked?Yes 53% On discussion question, Trusts ranged between 14% and 62% of their patients saying they’d had a discussion Cancer types ranged 15% - 39% having a discussion

NCPES: 2013 & 2014 Research Awareness Questions Have you seen information (such as leaflets, posters, information screens, etc.) about cancer research in your hospital? Since your diagnosis has anyone discussed with you whether you would like to take part in cancer research? If so did you then go on to take part in research?

NCPES Findings Seen information? Yes 86% 85% Had a discussion? Yes 31% 32% Go on to take part in research? Yes 63% 64%

Summarised by cancer types Was taking part in research discussed with you? Cancer type Brain34%38%37% Breast39%37%35% Colorectal36%32%29% Gynaecological28% 29% Head & Neck34%29%34% Haematology33%36%37% Lung35%31%30% Prostate35%34% Sarcoma33%34%35% Skin27%18%17% Upper GI38%35%34% Urological15%16%14% Other cancers36%33%35% Total33%32%31%

Summarised by cancer types Was taking part in research discussed with you? Cancer type Brain34%38%37% Breast39%37%35% Colorectal36%32%29% Gynaecological28% 29% Head & Neck34%29%34% Haematology33%36%37% Lung35%31%30% Prostate35%34% Sarcoma33%34%35% Skin27%18%17% Upper GI38%35%34% Urological15%16%14% Other cancers36%33%35% Total33%32%31%

Summarised by cancer types Was taking part in research discussed with you? Cancer type …if so, did you take part? 2014 …if so, did you take part? Brain34%38%70%37%75% Breast39%37%58%35%59% Colorectal36%32%65%29%61% Gynaecological28% 63%29%64% Head & Neck34%29%67%34%69% Haematology33%36%73%37%71% Lung35%31%62%30%58% Prostate35%34%62%34%58% Sarcoma33%34%72%35%64% Skin27%18%60%17%59% Upper GI38%35%61%34%63% Urological15%16%56%14%58% Other cancers36%33%58%35%63% Total33%32%64%31%63%

Summarised by cancer types Did you see information about cancer research? Cancer type Brain87%85% Breast87%88% Colorectal85%86% Gynaecological85%86% Head & Neck86%88% Haematology86%88% Lung88% Prostate85% Sarcoma86% Skin80% Upper GI86%88% Urological78% Other cancers85%88% Total85%86%

The Impact of Age Nearly a quarter of respondents are over 75 BUT less likely to be engaged by information about research Significantly less likely to have had a discussion and less likely to take part BUT, when asked to take part, participation of over 75s is over 50% Is this about the co-morbidities of the patient or the assumptions of the research community?

Variation Between Trusts 2014 Overall findings for all Trusts: Q.29: 86% Q.30: 31% Q.31: 63%

Variation Between Cancers

Variation Between Cancers 2014

Variation Between Cancers

Breast Patients:2012 QuestionsBreast patientsAll patientsRange Had Discussion? 39%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 56%53%47%-64%

Breast Patients: 2013 & 2014 QuestionsBreast 2013 All 2013 Breast 2014All 2014 Saw?87%85%88%86% Had Discussion?37%32%35%31% Went on to take part? 58%64%59%63%

Colorectal & Lower GI Patients:2012 Questions 2012 Colorectal patients All patients Range Had Discussion?36%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 51%53%47%-64%

Colorectal & Lower GI Patients: 2013 & 2014 QuestionsColorectal 2013 All 2013 Colorectal 2014 All 2014 Saw?85% 86% Had Discussion? 32% 29%31% Went on to take part ? 65%64%61%63%

Lung Patients: 2012 QuestionsLung patients All Patients Range Had Discussion?35%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 53% 47%-64%

Lung Patients: 2013 & 2014 Questions Lung 2013 All 2013 Lung 2014 All 2014 Saw?88%85%88%86% Had Discussion? 31%32%30%31% Went on to take part ? 62%64%58%63%

Prostate Patients:2012 Questions Prostate patients All patients Range Had Discussion?35%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 84%53%47%-64%

Prostate Patients: 2013 & 2014 Questions Prostate 2013 All 2013 Prostate 2014 All 2014 Saw?85% 86% Had Discussion? 34%32%34%31% Went on to take part ? 62%64%58%63%

Brain & CNS Patients:2012 Questions Brain & CNS patients All patients Range Had Discussion?34%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 64%53%47%-64%

Brain & CNS Patients: 2013 & 2014 Questions Brain & CNS 2013 All 2013 Brain & CNS 2014 All 2014 Saw? 87%85% 86% Had Discussion? 38%32%37%31% Went on to take part ? 70%64%75%63%

Gynaecological Patients:2012 Questions Gynae patients All patients Range Had Discussion?28%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 51%53%47%-64%

Gynaecological Patients: 2013 & 2014 Questions Gynae 2013 All 2013 Gynae 2014 All 2014 Saw?85% 86% Had Discussion? 28%32%29%31% Went on to take part ? 63%64% 63%

Haematological Patients: 2012 Questions Haem. patients All patients Range Had Discussion?33% 15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 53% 47%-64%

Haematology Patients: 2013 & 2014 QuestionsHaem All 2013 Haem All 2014 Saw?86%85%88%86% Had Discussion? 36%32%37%31% Went on to take part ? 73%64%71%63%

Head & Neck Patients: 2012 Questions Head & Neck patients All patients Range Had Discussion?24%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 54%53%47%-64%

Head & Neck Patients: 2013 & 2014 QuestionsHead & Neck 2013 All 2013 Head & Neck 2014 All 2014 Saw?86%85%88%86% Had Discussion? 29%32%34%31% Went on to take part ? 67%64%69%63%

Sarcoma Patients:2012 Questions Sarcoma patients All patients Range Had Discussion?24%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 59%53%47%-64%

Sarcoma Patients: 2013 & 2014 QuestionsSarcoma 2013 All 2013 Sarcoma 2014 All 2014 Saw?86%85%86% Had Discussion? 34%32%35%31% Went on to take part ? 72%64% 63%

Skin Patients:2012 Questions Skin patients All patients Range Had Discussion?27%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 47%53%47%-64%

Skin Patients:2013 & 2014 Questions Skin 2013 All 2013 Skin 2014 All 2014 Saw?80%85%80%86% Had Discussion? 18%32%17%31% Went on to take part ? 60%64%59%63%

Upper GI Patients: 2012 Questions Upper GI patients All patients Range Had Discussion?30%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 54%53%47%-64%

Upper GI Patients: 2013 & 2014 Questions Upper GI 2013 All 2013 Upper GI 2014 All 2014 Saw?86%85%88%86% Had Discussion? 35%32%34%31% Went on to take part ? 61%64%63%

Urology Patients:2012 Questions Urology patients All patients Range Had Discussion?15%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 47%53%47%-64%

Urology Patients: 2013 & 2014 Questions Urology 2013 All 2013 Urology 2014 All 2014 Saw?78%85%78%86% Had Discussion? 16%32%14%31% Went on to take part ? 58%64%56%63%

Other Cancers:2012 Questions 2012 Other patients All patients Range Had Discussion?36%33%15%-39% Glad? No significant differences between cancers 95% Would like to have been asked? 57%53%47%-64%

Other Cancers: 2013 & 2014 Questions 2013 & 2014 Other 2013 All 2013 Other 2014 All 2014 Saw?85% 87%86% Had Discussion?33%32%35%31% Went on to take part ? 68%64%63%

Variation by LCRN Geography

Regional variation in enrolment 48 Recruitment of cancer patients to research studies as a % of cancer incidence. Data shown for the 2 years before the start of LCRNs (April 2014), configured to the LCRN boundaries

Link between NCPES data and NIHR CRN Cancer recruitment 49 each represents data for Trusts in one LCRN geography

Involvement in Research = Better Patient Experience 2013 Did not have a discussion Had discussion but did not go on to participate Had discussion and did go on to participate Rating of care as excellent or very good Rating of care as less than excellent or very good 87.2% 12.8%  90.2% 9.8%  91.9% 8.1% Ref: Keeping the Customer Satisfied - It’s OK to Ask: Is Taking Part in Research Associated with Better Experience of Care? Findings from 2013 NCPES: Morris et al, 2014

Changing the culture How can we: improve awareness of research? improve access to opportunities to take part in research? ensure patients have conversations about taking part as a routine part of treatment choices? Improving NCPES results

Our action plan for 2015……. Improving NCPES results

Quality Health, Dr Reg Race SPADE (consumer-led Strategic PPI Advice, Delivery and Evaluation panel supported by NIHR CRN: Cancer) Communications and PPI Team at NIHR CRN Coordinating Centre NIHR CRN Cancer: NCPES Working Group (Consumers, Researchers, NCIN and NIHR CRN Cancer) Special thanks to Professor Robert West for analyses Working group chaired by Carolyn Morris: NCPES: Acknowledgements & Thanks

54 Why not add a photo to your presentation?

55 Why not add a photo to your presentation?

… let us know where you use the presentation... and what impact it had Send your feedback to: Thank you…….